AlphaCrest Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,902
| Closed | -$344K | – | 1420 |
|
|
2022
Q1 | $344K | Buy |
+2,902
| New | +$344K | 0.02% | 1061 |
|
|
2021
Q3 | – | Sell |
-3,104
| Closed | -$301K | – | 1441 |
|
|
2021
Q2 | $301K | Buy |
+3,104
| New | +$301K | 0.01% | 1107 |
|
|
2021
Q1 | – | Sell |
-4,455
| Closed | -$382K | – | 1370 |
|
|
2020
Q4 | $382K | Sell |
4,455
-4,345
| -49% | -$373K | 0.03% | 799 |
|
|
2020
Q3 | $572K | Buy |
8,800
+5,300
| +151% | +$345K | 0.06% | 522 |
|
|
2020
Q2 | $256K | Buy |
+3,500
| New | +$256K | 0.04% | 708 |
|